April 19, 2016
ARLINGTON, Va. — The HDMA-supported legislation, the Ensuring Patient Access and Effective Drug Enforcement Act (S. 483), was signed into law by President Obama today.
According to HDMA President and CEO John M. Gray, “Today’s enactment is a victory for not only supply chain stakeholders and regulators, who share a common goal in mitigating the scourge of prescription drug abuse in this country, but the many individuals who rely on life-enhancing pain medicines every day. The changes brought forth through this law strike the appropriate balance of further protecting the supply chain against drug diversion, while allowing continuing patient access to critical medicines — and it does so in a way that promotes collaboration between the healthcare supply chain and those who regulate it.
“As the first bill combatting prescription drug abuse to become law in the 114th Congress, we thank President Obama for his support and prompt attention to this important legislation. We also thank our legislative champions, Sens. Hatch (R-Utah), Whitehouse (D-R.I.), as well as Reps. Marino (R-Pa.), Blackburn (R-Tenn.) Welch (D-Vt.) and Chu (D-Calif.); their bicameral, bipartisan support buoyed this bill to enactment. We now will continue to work with our members, regulators — including the Drug Enforcement Administration — and supply chain partners to ensure that this law is implemented efficiently and effectively."
HDA is the national association representing primary healthcare distributors, the vital link between the nation’s pharmaceutical manufacturers and healthcare providers. Each business day, HDA member companies ensure that over 15 million prescription medicines and healthcare products are delivered safely and efficiently to more than 200,000 pharmacies, hospitals, long-term care facilities, clinics and others nationwide. HDA and its members work daily to provide value and achieve cost savings, an estimated $42 billion each year to our nation’s healthcare system.